4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001615774-18-003641
Options or other derivatives
- Chief Executive Officer acquired 100,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Carpenter George C IV Chief Executive Officer | 2017-09-18 | Grant or award · Employee Stock Option (right to purchase) | +100,000 | 100,000 | D | ||
Loading xslF345X03/s110118_form4.xml…